Back
Endava PLC Vs. Nektar Therapeutics Industry Stock Comparison
Sell
42
DAVA
Endava PLC
Last Price:
$13.65
Seasonality Move:
3.37%
Buy
54
NKTR
Nektar Therapeutics
Last Price:
$24.44
Seasonality Move:
3.38%
Sell
42
Endava PLC (DAVA)
is a Sell
Is Endava PLC a Buy, Sell or Hold?
-
The current Endava PLC [DAVA] share price is $13.66. The Score for DAVA is 42, which is 16% below its historic median score of 50, and infers higher risk than normal.
-
DAVA is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Buy
54
Nektar Therapeutics (NKTR)
is a Buy
Is Nektar Therapeutics a Buy, Sell or Hold?
-
The current Nektar Therapeutics [NKTR] share price is $24.41. The Score for NKTR is 54, which is 8% above its historic median score of 50, and infers lower risk than normal.
-
NKTR is currently trading in the 50-60% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
DAVA Stock Price Chart
What is Endava PLC's stock price today?
-
The Endava PLC share price today is $13.66Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and DAVA is experiencing slight selling pressure.
NKTR Stock Price Chart
What is Nektar Therapeutics's stock price today?
-
The Nektar Therapeutics share price today is $24.41Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and NKTR is experiencing slight buying pressure.
DAVA Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | -0.42 | Sell |
Relative Strength Index (14 RSI): | 34.85 | Sell |
Chaikin Money Flow: | -134169 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (14.26 - 16.08) | Sell |
Bollinger Bands (100): | (14.56 - 22.64) | Sell |
NKTR Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | 6.02 | Buy |
Relative Strength Index (14 RSI): | 63.8 | Buy |
Chaikin Money Flow: | 4197 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (10.12 - 26.32) | Buy |
Bollinger Bands (100): | (7.51 - 18.15) | Buy |
DAVA Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 14.68 | Sell |
20-day SMA: | 14.82 | Sell |
50-day SMA: | 15.97 | Sell |
200-day SMA: | 23.66 | Sell |
8-day EMA: | 14.42 | Sell |
20-day EMA: | 14.89 | Sell |
50-day EMA: | 15 | Sell |
200-day EMA: | 9.07 | Buy |
NKTR Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 24.3 | Buy |
20-day SMA: | 20.35 | Buy |
50-day SMA: | 14.3 | Buy |
200-day SMA: | 14.58 | Buy |
8-day EMA: | 17.41 | Buy |
20-day EMA: | 9.54 | Buy |
50-day EMA: | 4.38 | Buy |
200-day EMA: | 1.18 | Buy |
Endava PLC Earnings Growth & DAVA Earnings Dates
-
Analysts estimate an earnings increase this quarter of $0.09 per share, an increase next quarter of $0.03 per share, an increase this year of $0.01 per share, and an increase next year of $0.14 per share.
Nektar Therapeutics Earnings Growth & NKTR Earnings Dates
-
Analysts estimate an earnings increase this quarter of $0.36 per share, a decrease next quarter of $0.06 per share, an increase this year of $0.86 per share, and an increase next year of $0.01 per share.
Endava PLC Technical Analysis
Jun 30 | Jul 1 | Jul 2 | Jul 3 | Jul 7 | Jul 8 | Jul 9 | Jul 10 | Jul 11 | Jul 14 | |
---|---|---|---|---|---|---|---|---|---|---|
Jun | Jul | |||||||||
30 | 01 | 02 | 03 | 07 | 08 | 09 | 10 | 11 | 14 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |
Nektar Therapeutics Technical Analysis
Jun 30 | Jul 1 | Jul 2 | Jul 3 | Jul 7 | Jul 8 | Jul 9 | Jul 10 | Jul 11 | Jul 14 | |
---|---|---|---|---|---|---|---|---|---|---|
Jun | Jul | |||||||||
30 | 01 | 02 | 03 | 07 | 08 | 09 | 10 | 11 | 14 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |